Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Finasteride treatment makes the prostate look more like a healthy one.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Finasteride can cause melasma, especially in people with darker skin.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

JAK inhibitors are effective treatments for alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

An elderly Chinese man lost all his hair after taking a new heart medication.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Ritlecitinib helps adolescents with severe alopecia areata regrow scalp hair and normalize body hair and nails.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Dutasteride may reduce insulin sensitivity and increase body fat.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.